Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

EDAP TMS SA Announces Approval For Ablatherm-HIFU In Argentina

EDAP TMS SA announced that the Ministry of Health in Argentina has approved Ablatherm-HIFU (high-intensity focused ultrasound) as a minimally invasive treatment option for patients with localized prostate cancer. Argentina closely follows Brazil as the latest country in South America to approve the device.

Marc Oczachowski, EDAP’s Chief Executive Officer, commented, We are very pleased by the growing adoption and global expansion of Ablatherm-HIFU, particularly in South America with our entrance into new markets in Argentina and Brazil. These recent approvals mark a clear milestone for our technology as Ablatherm-HIFU gains further traction as a proven non-invasive therapeutic solution for prostate cancer.